(Q35015840)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12464150%20AND%20SRC:MED&resulttype=core&format=json

15 December 2019

review article

1 reference

title

Calcineurin inhibitors and sirolimus: mechanisms of action and applications in dermatology (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12464150%20AND%20SRC:MED&resulttype=core&format=json

15 December 2019

1 reference

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12464150%20AND%20SRC:MED&resulttype=core&format=json

15 December 2019

author name string

W I Al-Daraji

series ordinal

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12464150%20AND%20SRC:MED&resulttype=core&format=json

15 December 2019

publication date

1 October 2002

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12464150%20AND%20SRC:MED&resulttype=core&format=json

Clinical and Experimental Dermatology

15 December 2019

published in

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12464150%20AND%20SRC:MED&resulttype=core&format=json

15 December 2019

volume

27

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12464150%20AND%20SRC:MED&resulttype=core&format=json

15 December 2019

issue

7

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12464150%20AND%20SRC:MED&resulttype=core&format=json

15 December 2019

page(s)

555-561

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12464150%20AND%20SRC:MED&resulttype=core&format=json

Calcineurin-immunosuppressor complexes

15 December 2019

cites work

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2230.2002.01148.X

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2230.2002.01148.X

Monitoring the duration of antigen-receptor occupancy by calcineurin/glycogen-synthase-kinase-3 control of NF-AT nuclear shuttling.

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2230.2002.01148.X

Gene regulation mediated by calcium signals in T lymphocytes

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2230.2002.01148.X

Calcineurin is a common target of cyclophilin-cyclosporin A and FKBP-FK506 complexes

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2230.2002.01148.X

Expression of NFAT-family proteins in normal human T cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2230.2002.01148.X

Transcription factors of the NFAT family: regulation and function

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2230.2002.01148.X

Two distinct action mechanisms of immunophilin-ligand complexes for the blockade of T-cell activation

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2230.2002.01148.X

FK506 and Cyclosporin A Each Inhibit Antigen-Specific Signaling in the T Cell Line 171 in the Absence of a Calcium Signal

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2230.2002.01148.X

Affinity-driven peptide selection of an NFAT inhibitor more selective than cyclosporin A.

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2230.2002.01148.X

A calcineurin-NFATc3-dependent pathway regulates skeletal muscle differentiation and slow myosin heavy-chain expression.

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2230.2002.01148.X

The transcription factor NF-ATc is essential for cardiac valve formation

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2230.2002.01148.X

Role of the NF-ATc transcription factor in morphogenesis of cardiac valves and septum

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2230.2002.01148.X

NF-AT components define a family of transcription factors targeted in T-cell activation

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2230.2002.01148.X

Cross talk among calcineurin, Sp1/Sp3, and NFAT in control of p21(WAF1/CIP1) expression in keratinocyte differentiation

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2230.2002.01148.X

Generic signals and specific outcomes: signaling through Ca2+, calcineurin, and NF-AT

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2230.2002.01148.X

Chemokine production by G protein-coupled receptor activation in a human mast cell line: roles of extracellular signal-regulated kinase and NFAT.

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2230.2002.01148.X

Tacrolimus (FK 506)--a new therapeutic agent for severe recalcitrant psoriasis

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2230.2002.01148.X

Double-blind, controlled, crossover study of cyclosporin in adults with severe refractory atopic dermatitis

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2230.2002.01148.X

Efficacy of sirolimus (rapamycin) administered concomitantly with a subtherapeutic dose of cyclosporin in the treatment of severe psoriasis: a randomized controlled trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2230.2002.01148.X

Tacrolimus and pimecrolimus: from clever prokaryotes to inhibiting calcineurin and treating atopic dermatitis

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2230.2002.01148.X

Ascomycin: an advance in the management of atopic dermatitis

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2230.2002.01148.X

Sensitivity to sunburn is associated with susceptibility to ultraviolet radiation-induced suppression of cutaneous cell-mediated immunity

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2230.2002.01148.X

Efficacy of sirolimus compared with azathioprine for reduction of acute renal allograft rejection: a randomised multicentre study

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2230.2002.01148.X

Oral cyclosporine in the treatment of inflammatory and noninflammatory dermatoses. A clinical and immunopathologic analysis

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2230.2002.01148.X

T lymphocyte activation signals for interleukin-2 production involve activation of MKK6-p38 and MKK7-SAPK/JNK signaling pathways sensitive to cyclosporin A

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2230.2002.01148.X

Sirolimus and cyclosporin for renal transplantation

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2230.2002.01148.X

Cyclosporine improves psoriasis in a double-blind study

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2230.2002.01148.X

Renal function after 10 years' treatment with cyclosporin for psoriasis

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2230.2002.01148.X

Systemic toxicity following administration of sirolimus (formerly rapamycin) for psoriasis: association of capillary leak syndrome with apoptosis of lesional lymphocytes

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2230.2002.01148.X

Intralesional cyclosporine for psoriasis. Relationship of dose, tissue levels, and efficacy

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2230.2002.01148.X

Topical tacrolimus is not effective in chronic plaque psoriasis. A pilot study

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2230.2002.01148.X

10.1046/J.1365-2230.2002.01148.X

21 January 2018

Identifiers

DOI

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12464150%20AND%20SRC:MED&resulttype=core&format=json

15 December 2019

1 reference